Mitchell S Levine - Net Worth and Insider Trading
Mitchell S Levine Net Worth
The estimated net worth of Mitchell S Levine is at least $12,409 dollars as of 2024-09-30. Mitchell S Levine is the CFO of OncoCyte Corp and owns about 4,354 shares of OncoCyte Corp (OCX) stock worth over $12,409. Details can be seen in Mitchell S Levine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mitchell S Levine has not made any transactions after 2022-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mitchell S Levine
Mitchell S Levine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mitchell S Levine owns 2 companies in total, including OncoCyte Corp (OCX) , and Cloudward Inc (CDWD) .
Click here to see the complete history of Mitchell S Levine’s form 4 insider trades.
Insider Ownership Summary of Mitchell S Levine
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCX | OncoCyte Corp | 2022-03-15 | Chief Financial Officer |
| CDWD | Cloudward Inc | 2010-12-31 | 10 percent owner |
Mitchell S Levine Latest Holdings Summary
Mitchell S Levine currently owns a total of 1 stock. Mitchell S Levine owns 4,354 shares of OncoCyte Corp (OCX) as of March 15, 2022, with a value of $12,409.
Latest Holdings of Mitchell S Levine
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCX | OncoCyte Corp | 2022-03-15 | 4,354 | 2.85 | 12,409 |
Holding Weightings of Mitchell S Levine
Mitchell S Levine Form 4 Trading Tracker
According to the SEC Form 4 filings, Mitchell S Levine has made a total of 3 transactions in OncoCyte Corp (OCX) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in OncoCyte Corp is the acquisition of 1,250 shares on March 15, 2022, which cost Mitchell S Levine around $29,250.
Insider Trading History of Mitchell S Levine
- 1
Mitchell S Levine Trading Performance
GuruFocus tracks the stock performance after each of Mitchell S Levine's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mitchell S Levine is 13.49%. GuruFocus also compares Mitchell S Levine's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mitchell S Levine within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mitchell S Levine's insider trading performs compared to the benchmark.
Performance of Mitchell S Levine
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.15 | | | | | |
| Relative Return to S&P 500(%) | -7.36 | | | | | |
Mitchell S Levine Ownership Network
Mitchell S Levine Owned Company Details
What does OncoCyte Corp do?
Who are the key executives at OncoCyte Corp?
Mitchell S Levine is the Chief Financial Officer of OncoCyte Corp. Other key executives at OncoCyte Corp include 10 percent owner Broadwood Partners Lp , Interim CEO Josh Riggs , and other: Former Director John Peter Gutfreund .
OncoCyte Corp (OCX) Insider Trades Summary
Over the past 18 months, Mitchell S Levine made no insider transaction in OncoCyte Corp (OCX). Other recent insider transactions involving OncoCyte Corp (OCX) include a net purchase of 29,247,638 shares made by Broadwood Partners Lp , a net purchase of 663,000 shares made by Pura Vida Investments, Llc , and a net purchase of 33,898 shares made by Andrew Arno .
In summary, during the past 3 months, insiders sold 0 shares of OncoCyte Corp (OCX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of OncoCyte Corp (OCX) were sold and 3,833,320 shares were bought by its insiders, resulting in a net purchase of 3,833,320 shares.
OncoCyte Corp (OCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
OncoCyte Corp Insider Transactions
Mitchell S Levine Mailing Address
Above is the net worth, insider trading, and ownership report for Mitchell S Levine. You might contact Mitchell S Levine via mailing address: One Ferry Building, Suite 255, San Francisco Ca 94111.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
